Vascular‐endothelial‐growth‐factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vascular‐endothelial‐growth‐factor (VEGF) Targeting Therapies for Endocrine Refractory or Resistant Metastatic Breast Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435567/all/Vascular‐endothelial‐growth‐factor__VEGF__targeting_therapies_for_endocrine_refractory_or_resistant_metastatic_breast_cancer_New. Accessed 29 March 2024.
Vascular‐endothelial‐growth‐factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435567/all/Vascular‐endothelial‐growth‐factor__VEGF__targeting_therapies_for_endocrine_refractory_or_resistant_metastatic_breast_cancer_New. Accessed March 29, 2024.
Vascular‐endothelial‐growth‐factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435567/all/Vascular‐endothelial‐growth‐factor__VEGF__targeting_therapies_for_endocrine_refractory_or_resistant_metastatic_breast_cancer_New
Vascular‐endothelial‐growth‐factor (VEGF) Targeting Therapies for Endocrine Refractory or Resistant Metastatic Breast Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435567/all/Vascular‐endothelial‐growth‐factor__VEGF__targeting_therapies_for_endocrine_refractory_or_resistant_metastatic_breast_cancer_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vascular‐endothelial‐growth‐factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer
ID - 435567
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435567/all/Vascular‐endothelial‐growth‐factor__VEGF__targeting_therapies_for_endocrine_refractory_or_resistant_metastatic_breast_cancer_New
DB - Evidence Central
DP - Unbound Medicine
ER -